The Engagement Advantage: Making GLP-1s Work Harder 

Session details:

With over 75 percent of U.S. adults actively trying to lose weight, GLP-1 medications have emerged as a powerful option—but long-term adherence remains low. This session explores how lasting outcomes require a holistic, provider-guided approach that integrates medication, clinical oversight, and technology to drive behavior change and continuous patient engagement. Discover why GLP-1s are just one piece of the puzzle and how personalized plans can improve safety, adherence, and results.